Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery for Patients With Medically Refractory Myocardial Ischemia and Risk Factors for Adverse Outcomes With Bypass: A Multicenter, Randomized Trial

Douglass A. Morrison, MD, FACC,* Gulshan Sethi, MD, FACC,* Jerome Sacks, PHD,† William Henderson, PHD,† Frederick Grover, MD, FACC,‡ Steven Sedlis, MD, FACC,§ Rick Esposito, MD,§ Kodangudi Ramanathan, MD, FACC,\ Darryl Weiman, MD,\ Jorge Saucedo, MD,¶ Tamim Antakli, MD,¶ Venki Paramesh, MD,* Stuart Pett, MD,# Sarah Vernon, MD, FACC,# Vladimir Birjiniuk, MD,** Frederick Welt, MD,** Mitchell Krucoff, MD, FACC,†† Walter Wolfe, MD, FACC,†† John C. Lucke, MD,‡‡ Sundeep Mediratta, MD,‡‡ David Booth, MD, FACC,§§ Charles Barbiere, CCRN,‡ Daniel Lewis, MD, FACC,\ \ for the Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) Tucson, Arizona; Denver, Colorado; New York, New York; Memphis, Tennessee; Little Rock, Arkansas; Albuquerque, New Mexico; West Roxbury, Massachusetts; Durham and Asheville, North Carolina; Lexington, Kentucky; and Kansas City, Missouri